Updated:
BioVentrix
OUR VISION: Extend Life Span and Improve Quality of Life for Heart Failure Patients OUR VISION Extending Life Span and Improving Quality of Life for Heart...
Overview
OUR VISION: Extend Life Span and Improve Quality of Life for Heart Failure Patients OUR VISION Extending Life Span and Improving Quality of Life for Heart Failure Patients How Revivent Therapy May Treat Heart Failure How Revivent Therapy May Treat Heart Failure Revivent
General information
Location
Region
North America
Country
United States
City
Mansfield
Corporate office
Mansfield, MA, United States
Additional offices
San Ramon, CA, United States
Principals
Carl Byrnes
Chief Financial Officer
Sector focus
Frequently asked questions
What stage of development is Revivent Therapy in?
Revivent Therapy is investigational and currently being evaluated in the RELIVE clinical trial, a prospective multi-center randomized study. The trial enrolls approximately 135 subjects and is registered on ClinicalTrials.gov. The therapy is not yet approved by regulators like the FDA.
What geographic markets does BioVentrix operate in?
BioVentrix's headquarters are in Mansfield, Massachusetts, with an office in San Ramon, California. In Europe, the company has secured a reimbursement designation in Germany, making 91 hospitals eligible to negotiate coverage for Revivent Therapy as of March 2026 (per firm press release).
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: